Japan passes bill to raise co-payments for prescription drugs similar to OTC counterparts

The Diet passed legislation requiring higher co-payments for about 1,100 prescription drugs that resemble over-the-counter products, with the changes set to begin in March 2027.

The health ministry will require individuals to cover additional costs for these medications under the new rules.

The bill targets drugs similar to existing over-the-counter options as part of efforts to adjust national health insurance expenses.

Implementation is scheduled for March 2027.

Articles connexes

The government has decided to broaden an investigation into the international pharmaceutical market following reports of shortages in estrogen medications.

Rapporté par l'IA

Bundestag and Bundesrat have passed the contested savings package of the black-red coalition on health expenditures. The goal is to prevent rising contributions for statutory health insurance funds.

Ce site utilise des cookies

Nous utilisons des cookies pour l'analyse afin d'améliorer notre site. Lisez notre politique de confidentialité pour plus d'informations.
Refuser